Third Annual New York Lung Cancer Symposium

3500 Maple Avenue, Suite 700
Dallas, Texas

Schedule of Presentations:

Tuesday, November 6, 2007
07:30:00 Registration and Continental Breakfast
08:00:00 Welcome and Introductions
08:05:00 Update on Key Data on Anti-VEGF Antibodies
08:25:00 Predicting Response and Resistance to Antiangiogenic Agents
08:45:00 Novel Antiangiogenic Agents John Heymach
09:05:00 Panel Discussion
10:00:00 Recent Advances in First-line Therapy of Metastatic NSCLC Nasser H. Hanna
10:20:00 Surgical Approaches to Early-Stage NSCLC Harvey Pass
10:40:00 Current State of Adjuvant Chemotherapy Mark Kris
11:00:00 Combinations of Chemotherapy and EGFR Inhibitors Roman Perez-Soler
11:20:00 What’s New in SCLC Therapy Charles M Rudin
11:40:00 New Developments for Patients With Mesothelioma David Sugarbaker
12:00:00 New Presentation
12:00:00 New Presentation
12:00:00 Panel Discussion
12:20:00 Break for Lunch
12:35:00 Lunch Case Discussions Nasser H. Hanna
13:35:00 Kyphoplasty Eric Lis
13:55:00 Erythropoietin-Stimulating Agents Richard Gralla
14:15:00 Dermatologic Toxicities Mario Lacouture
14:35:00 RFA/Cryoablation Stephen Solomon
14:55:00 Hypertension Michael L. Maitland
15:15:00 Panel Discussion
15:35:00 Targeting the IGF Axis Giuseppe Giaccone
15:55:00 Strategies to Overcome Acquired Resistance to EGFR TKIs Vincent A Miller
16:15:00 Selecting Patients for EGFR TKI Therapy Lecia Sequist
16:35:00 Panel Discussion
16:55:00 Adjourn
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.